glp 1 for iih The protective role of GLP-1 in neuro-ophthalmology Idiopathic Intracranial Hypertension | New

Switch GHK-Cu to TB-500 When: The wound or injury is acute and lacks neovascularization Serum or tissue copper is already in the upper normal range (reducing the marginal benefit of further copper delivery) The target tissue is muscle or tendon rather than skin or superficial connective tissue Prior GHK-Cu trial at 8 to 12 weeks showed no measurable change in tissue architecture Thymosin beta-4 knockout mouse models consistently demonstrate impaired wound healing specifically at the angiogenesis and re-epithelialization stages, not at late-stage matrix remodeling [1]

However, recent drug discoveries and targeted therapies indicate evidence for durable remissions but no guaranty can be given yet on drug resistance 2

Hanna AA, B.: Hanna, A

Worcester, E